NCT06650046

Brief Summary

Lumbar degenerative disease is a common disease among middle-aged and elderly people as well as those who sit for a long time, mainly manifested as symptoms such as lower back pain, stiffness, and numbness in the lower limbs. Traditional surgical treatments such as lumbar fusion can alleviate symptoms, but may lead to complications such as adjacent segment degeneration. Therefore, exploring safer and more effective treatment methods is of great significance. Topping off technique, as a new treatment method, combines the advantages of interbody fusion and dynamic fixation, aiming to reduce the pressure on the intervertebral disc at the surgical site, promote the repair of diseased intervertebral discs, while preserving partial mobility of the lumbar spine.The aim of this study is to evaluate the clinical efficacy and imaging changes of Topping off technique in the treatment of lumbar degenerative diseases. The Topping off technique combines posterior lumbar interbody fusion (PLIF) and Wallis interspinous dynamic fixation device implantation. Through prospective clinical trials, its therapeutic effect on patients with continuous double segment lumbar degenerative diseases was observed. The study included patients who underwent surgery for degenerative lumbar diseases in L4-5 and L5-S1, who were treated with two-stage fusion surgery and Topping off technique, respectively. Follow up was conducted before and after surgery, with an average follow-up time of 24 months. Evaluate preoperative and postoperative efficacy using Oswestry Disability Index (ODI), Pain Visual Analog Scale (VAS), and Japanese Orthopaedic Association (JOA) lumbar spine function score, and calculate recovery rate. At the same time, X-ray and MRI images were used to detect the overall range of motion (L2\~S1ROM) of the lumbar spine, the range of motion (ROM) of the Wallis device inserted segments, the intervertebral disc height index (DHI), and the relative signal intensity of the nucleus pulposus (RSI) of the intervertebral disc.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
44mo left

Started Oct 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress30%
Oct 2024Dec 2029

First Submitted

Initial submission to the registry

October 15, 2024

Completed
3 days until next milestone

Study Start

First participant enrolled

October 18, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 21, 2024

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2029

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2029

Last Updated

October 21, 2024

Status Verified

October 1, 2024

Enrollment Period

4.8 years

First QC Date

October 15, 2024

Last Update Submit

October 17, 2024

Conditions

Keywords

Topping-off technique

Outcome Measures

Primary Outcomes (3)

  • VAS

    The visual analog scale (VAS) is used for pain assessment. It is widely used in clinical practice in China, and the basic method is to use a vernier ruler with a length of about 10cm, marked with 10 scales on one side, with both ends \- Page 3 of 5 \[DRAFT\] - The visual analog scale (VAS) is used for pain assessment. It is widely used in clinical practice in China, and the basic method is to use a vernier ruler with a length of about 10cm, marked with 10 scales on one side, with both ends marked as "0" and "10" respectively. A score of 0 indicates painlessness, and a score of 10 represents the most severe pain that cannot be tolerated. pain that cannot be tolerated.

    2 Years

  • JOA

    The Japanese Orthopaedic Association Scores (JOA) is a neurological function scoring system recommended by the Japanese Orthopaedic Association, which includes four parts: upper limb motor function, lower limb motor function, sensory and bladder function, with a total score of 29 points. The lower the score, the more severe the neurological dysfunction.

    2 Years

  • Cobb angle of surgical space and adjacent space in neutral position, over extension and over flexion position

    Cobb angle of surgical space and adjacent space in neutral position, over extension and over flexion position

    2 Years

Secondary Outcomes (3)

  • Lumbar spine overall range of motion (L2~S1ROM)

    2 Years

  • Wallis device insertion segment mobility (ROM)

    2 Years

  • Intervertebral Disc Height Index (DHI)

    2 Years

Study Arms (2)

Topping-off group

EXPERIMENTAL

Topping-off group Patients who have undergone the Topping-off surgery for lumbar spondylosis and have complete follow-up data and meet the standards completed at the First Affiliated Hospital of Shandong First Medical University.

Procedure: Topping-off GroupProcedure: Fusion Group

Fusion group

ACTIVE COMPARATOR

Patients who have undergone lumbar spine fusion surgery due to lumbar spondylosis and meet the standards and have complete follow-up data completed at the First Affiliated Hospital of Shandong First Medical University.

Procedure: Topping-off GroupProcedure: Fusion Group

Interventions

Topping-off group Patients who have undergone the Topping-off system insertion surgery for lumbar spondylosis and have complete follow-up data and meet the standards completed at the First Affiliated Hospital of Shandong First Medical University. Fusion group Patients who have undergone lumbar spine fusion surgery due to lumbar spondylosis and meet the standards and have complete follow-up data completed at the First Affiliated Hospital of Shandong First Medical University.

Fusion groupTopping-off group
Fusion GroupPROCEDURE

Topping-off group Patients who have undergone the Topping-off system insertion surgery for lumbar spondylosis and have complete follow-up data and meet the standards completed at the First Affiliated Hospital of Shandong First Medical University. Fusion group Patients who have undergone lumbar spine fusion surgery due to lumbar spondylosis and meet the standards and have complete follow-up data completed at the First Affiliated Hospital of Shandong First Medical University.

Fusion groupTopping-off group

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The patient's clinical manifestations, physical examination, and imaging data all support the diagnosis of degenerative lumbar spondylosis.
  • Those who have undergone strict and formal conservative treatment for at least 3 months before surgery and have no significant improvement in symptoms.
  • Preoperative imaging examination showed L4-5 and L5-S1 responsible segment protrusion or protrusion leading to segment stenosis.
  • Surgeries are performed by the same chief surgeon.

You may not qualify if:

  • Lumbar instability, lumbar spondylolisthesis above grade II.
  • Patients with severe osteoporosis, tuberculosis, or tumors.
  • Systemic diseases that affect surgical treatment and medication, such as heart disease, liver disease, and kidney disease.
  • Patients with mental illness, poor compliance, and inability to cooperate in completing follow-up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Shandong First Medical University

Jinan, Shandong, 250000, China

RECRUITING

Study Officials

  • Hao-Xuan Zhang, Ph.D/MD

    Shandong First Medical University

    STUDY CHAIR

Central Study Contacts

Hao-Xuan Zhang, Ph.D/MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 15, 2024

First Posted

October 21, 2024

Study Start

October 18, 2024

Primary Completion (Estimated)

July 31, 2029

Study Completion (Estimated)

December 31, 2029

Last Updated

October 21, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations